GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Short-Term Debt

G.Barekat Pharm (XTEH:BRKT1) Short-Term Debt : IRR10,315,378 Mil (As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Short-Term Debt?

G.Barekat Pharm's Short-Term Debt for the quarter that ended in Mar. 2017 was IRR10,315,378 Mil.

G.Barekat Pharm's quarterly Short-Term Debt stayed the same from . 20 (IRR0 Mil) to Mar. 2016 (IRR0 Mil) but then increased from Mar. 2016 (IRR0 Mil) to Mar. 2017 (IRR10,315,378 Mil).

G.Barekat Pharm's annual Short-Term Debt stayed the same from . 20 (IRR0 Mil) to Mar. 2016 (IRR0 Mil) but then increased from Mar. 2016 (IRR0 Mil) to Mar. 2017 (IRR10,315,378 Mil).

G.Barekat Pharm Short-Term Debt Historical Data

The historical data trend for G.Barekat Pharm's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Short-Term Debt Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Short-Term Debt
- 10,315,378.00

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Short-Term Debt - 10,315,378.00

G.Barekat Pharm Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

G.Barekat Pharm Short-Term Debt Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Short-Term Debt
Comparable Companies
PRGBQ BOM:532041 PZRXQ NSPX HSTC BOM:540108 XCNQ:ZRO XSAT:EURI B BOM:524604 BOM:532905 VODG BOM:506365 SOAN TSXV:WAVE PTEO BPSR CBBT LSE:PEBI ADYNF NTRR
Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
Website
http://www.bpharmed.com
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines